Stay updated on Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.

Latest updates to the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov record for the paltusotine acromegaly study is accessible, with its study details and results information displayed. It also indicates that the study ended early for business reasons and is no longer recruiting participants.SummaryDifference64%

- Check8 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide notice about NIH website changes and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page content.SummaryDifference1%

- Check22 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page remains a 403 Forbidden error page, with the displayed site revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check50 days agoChange DetectedThe PATHFNDR-1 study page now shows a 403 Forbidden error, and the detailed study content and documents are no longer visible on the page.SummaryDifference18%

Stay in the know with updates to Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.